Who
Snehal Patel
CEO and CFO
Company insider
Files Form 4 as: CEO and CFO, Greenwich LifeSciences.
In numbers
- Trades disclosed
- 127
- Buys
- 86
- Sells
- 0
- Bought
- $7.7M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Sep 2020
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $9,170700 at $13.10 | filing |
| 29 Jul 2026filed 30 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $9,170700 at $13.10 | filing |
| 28 Jul 2026filed 30 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $20K1,500 at $13.59 | filing |
| 28 Jul 2026filed 30 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $20K1,500 at $13.59 | filing |
| 27 Jul 2026filed 29 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $20K1,500 at $13.62 | filing |
| 27 Jul 2026filed 29 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $20K1,500 at $13.62 | filing |
| 24 Jul 2026filed 27 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $14K1,100 at $12.88 | filing |
| 24 Jul 2026filed 27 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $14K1,100 at $12.88 | filing |
| 23 Jul 2026filed 27 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $33K2,500 at $13.14 | filing |
| 23 Jul 2026filed 27 Jul 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $33K2,500 at $13.14 | filing |
| 13 Jan 2026filed 15 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $54K1,800 at $29.83 | filing |
| 13 Jan 2026filed 15 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $54K1,800 at $29.83 | filing |
| 12 Jan 2026filed 14 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $80K2,900 at $27.54 | filing |
| 12 Jan 2026filed 14 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $80K2,900 at $27.54 | filing |
| 31 Dec 2025filed 5 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $92K4,300 at $21.36 | filing |
| 31 Dec 2025filed 5 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $92K4,300 at $21.36 | filing |
| 30 Dec 2025filed 2 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $63K2,900 at $21.73 | filing |
| 30 Dec 2025filed 2 Jan 2026 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $63K2,900 at $21.73 | filing |
| 18 Dec 2025filed 19 Dec 2025 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $52K4,100 at $12.62 | filing |
| 25 Nov 2025filed 28 Nov 2025 | GLSI Greenwich LifeSciencesBiotechnology | SEC FORM 4 Bought | $39K4,600 at $8.37 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.